STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Meda (STO:MEDAA) expands the collaboration with the French development company Ethypharm for the patented product Axorid. New territories, such as East Europe with Russia and Turkey, are now included in the collaboration. Previously, Meda held commercialization rights in Central and West Europe.
